An Overview of the Challenging Process of Prior Authorization: Medical Necessity for a Better Way.

Clin Gastroenterol Hepatol

Wichita Falls Gastroenterology Associates, Wichita Falls, Texas.

Published: December 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604005PMC
http://dx.doi.org/10.1016/j.cgh.2024.09.001DOI Listing

Publication Analysis

Top Keywords

overview challenging
4
challenging process
4
process prior
4
prior authorization
4
authorization medical
4
medical necessity
4
necessity better
4
overview
1
process
1
prior
1

Similar Publications

This review highlights the integration of drug repurposing and nanotechnology-driven delivery strategies as innovative approaches to enhance the antifungal activity of statins against mucosal candidiasis, providing a framework for future translational research and clinical application. The rising prevalence of antifungal resistance and virulence factors of Candida albicans underscore the limitations of current therapies. Statins, commonly used as lipid-lowering agents, have emerged as attractive repurposed drug candidates due to their ability to interfere with fungal ergosterol biosynthesis and Ras-mediated signaling pathways.

View Article and Find Full Text PDF

The emergence of organoid models has significantly bridged the gap between traditional cell cultures/animal models and authentic human disease states, particularly for genetic disorders, where their inherent genetic fidelity enables more biologically relevant research directions and enhances translational validity. This review systematically analyzes established organoid models of genetic diseases across organs (e.g.

View Article and Find Full Text PDF

Nanotechnology for CAR T cells and tumour-infiltrating lymphocyte therapies.

Nat Nanotechnol

September 2025

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.

Adoptive T-cell therapies, and particularly CAR T cells and tumour-infiltrating lymphocytes, have transformed cancer treatment by selectively targeting malignant cells. Despite their clinical success, these therapies face substantial challenges, including costly manufacturing processes and tumour-imposed barriers that limit efficacy. Advances in understanding the nanoscale mechanisms governing T-cell activation and the role of the tumour microenvironment in restricting T-cell responses have driven the development of nanotechnology-based strategies that integrate key chemical and physical cues.

View Article and Find Full Text PDF

Deep brain stimulation (DBS) is an emerging treatment for otherwise treatment-refractory psychiatric disorders. It can produce remarkable clinical results in expert hands, but has not fared as well in controlled, multisite trials. That difficulty with scaling up arises in part because DBS' mechanisms are poorly understood, meaning that it is difficult to objectively identify patients likely to respond and/or to customize stimulation to match individual patients' needs.

View Article and Find Full Text PDF

Animal models of obesity.

Methods Cell Biol

September 2025

Department of Basic Sciences, Faculty of Medicine and Sciences, Universidad San Sebastián, Santiago, Chile. Electronic address:

Obesity is a multifactorial disease characterized by excessive accumulation of adipose tissue, resulting from an imbalance between energy intake and expenditure. Mouse models have emerged as invaluable tools for elucidating the complex genetic, environmental, and physiological mechanisms driving to obesity. This chapter provides an overview of the methodologies employed to establish and study obesity in mice, highlighting their relevance to human disease.

View Article and Find Full Text PDF